FDA Inspection 1071051 — Rocky Mountain Tissue Bank
The FDA completed an inspection of Rocky Mountain Tissue Bank on Oct 17, 2018 in Aurora, CO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 17, 2018
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Aurora, CO (United States)